Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Insight Molecular Diagnostics (IMDX) Depreciation & Amortization (IS) (2024 - 2026)

Insight Molecular Diagnostics' Depreciation & Amortization (IS) history spans 2 years, with the latest figure at $563000.0 for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (IS) changed 0.0% to $563000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $2.2 million, a 40.47% increase, with the full-year FY2025 number at $2.2 million, up 40.47% from a year prior.
  • Depreciation & Amortization (IS) hit $563000.0 in Q4 2025 for Insight Molecular Diagnostics, down from $584000.0 in the prior quarter.
  • Over the last five years, Depreciation & Amortization (IS) for IMDX hit a ceiling of $584000.0 in Q3 2025 and a floor of $326000.0 in Q2 2024.